Journal article

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

BD Behounek, ME McGovern, KB Kassler-Taub, JS Markowitz, M Bergman, P Colman, F Martin, D Colquhoun, I Hamilton-Craig, H Newman, D Wilcken

Arquivos Brasileiros de Medicina | Published : 1994